Visiomed Group SA
PAR:ALVMG

Watchlist Manager
Visiomed Group SA Logo
Visiomed Group SA
PAR:ALVMG
Watchlist
Price: 0.1726 EUR -1.82%
Market Cap: 53.1m EUR
Have any thoughts about
Visiomed Group SA?
Write Note

Intrinsic Value

The intrinsic value of one ALVMG stock under the Base Case scenario is 0.3843 EUR. Compared to the current market price of 0.1726 EUR, Visiomed Group SA is Undervalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALVMG Intrinsic Value
0.3843 EUR
Undervaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Visiomed Group SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALVMG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALVMG?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Visiomed Group SA

Provide an overview of the primary business activities
of Visiomed Group SA.

What unique competitive advantages
does Visiomed Group SA hold over its rivals?

What risks and challenges
does Visiomed Group SA face in the near future?

Has there been any significant insider trading activity
in Visiomed Group SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Visiomed Group SA.

Provide P/S
for Visiomed Group SA.

Provide P/E
for Visiomed Group SA.

Provide P/OCF
for Visiomed Group SA.

Provide P/FCFE
for Visiomed Group SA.

Provide P/B
for Visiomed Group SA.

Provide EV/S
for Visiomed Group SA.

Provide EV/GP
for Visiomed Group SA.

Provide EV/EBITDA
for Visiomed Group SA.

Provide EV/EBIT
for Visiomed Group SA.

Provide EV/OCF
for Visiomed Group SA.

Provide EV/FCFF
for Visiomed Group SA.

Provide EV/IC
for Visiomed Group SA.

Show me price targets
for Visiomed Group SA made by professional analysts.

What are the Revenue projections
for Visiomed Group SA?

How accurate were the past Revenue estimates
for Visiomed Group SA?

What are the Net Income projections
for Visiomed Group SA?

How accurate were the past Net Income estimates
for Visiomed Group SA?

What are the EPS projections
for Visiomed Group SA?

How accurate were the past EPS estimates
for Visiomed Group SA?

What are the EBIT projections
for Visiomed Group SA?

How accurate were the past EBIT estimates
for Visiomed Group SA?

Compare the revenue forecasts
for Visiomed Group SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Visiomed Group SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Visiomed Group SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Visiomed Group SA compared to its peers.

Compare the P/E ratios
of Visiomed Group SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Visiomed Group SA with its peers.

Analyze the financial leverage
of Visiomed Group SA compared to its main competitors.

Show all profitability ratios
for Visiomed Group SA.

Provide ROE
for Visiomed Group SA.

Provide ROA
for Visiomed Group SA.

Provide ROIC
for Visiomed Group SA.

Provide ROCE
for Visiomed Group SA.

Provide Gross Margin
for Visiomed Group SA.

Provide Operating Margin
for Visiomed Group SA.

Provide Net Margin
for Visiomed Group SA.

Provide FCF Margin
for Visiomed Group SA.

Show all solvency ratios
for Visiomed Group SA.

Provide D/E Ratio
for Visiomed Group SA.

Provide D/A Ratio
for Visiomed Group SA.

Provide Interest Coverage Ratio
for Visiomed Group SA.

Provide Altman Z-Score Ratio
for Visiomed Group SA.

Provide Quick Ratio
for Visiomed Group SA.

Provide Current Ratio
for Visiomed Group SA.

Provide Cash Ratio
for Visiomed Group SA.

What is the historical Revenue growth
over the last 5 years for Visiomed Group SA?

What is the historical Net Income growth
over the last 5 years for Visiomed Group SA?

What is the current Free Cash Flow
of Visiomed Group SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Visiomed Group SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Visiomed Group SA

Current Assets 5.3m
Cash & Short-Term Investments 3m
Receivables 2.3m
Non-Current Assets 31.3m
Long-Term Investments 1.2m
PP&E 5.2m
Intangibles 25m
Current Liabilities 3.1m
Accounts Payable 2.1m
Accrued Liabilities 827k
Other Current Liabilities 207k
Non-Current Liabilities 9.4m
Long-Term Debt 7.9m
Other Non-Current Liabilities 1.5m
Efficiency

Earnings Waterfall
Visiomed Group SA

Revenue
13.7m EUR
Cost of Revenue
-789k EUR
Gross Profit
12.9m EUR
Operating Expenses
-12.7m EUR
Operating Income
230k EUR
Other Expenses
672k EUR
Net Income
902k EUR

Free Cash Flow Analysis
Visiomed Group SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALVMG Profitability Score
Profitability Due Diligence

Visiomed Group SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

Visiomed Group SA's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ALVMG Solvency Score
Solvency Due Diligence

Visiomed Group SA's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
65/100
Solvency
Score

Visiomed Group SA's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALVMG Price Targets Summary
Visiomed Group SA

Wall Street analysts forecast ALVMG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALVMG is 0.714 EUR with a low forecast of 0.707 EUR and a high forecast of 0.735 EUR.

Lowest
Price Target
0.707 EUR
310% Upside
Average
Price Target
0.714 EUR
314% Upside
Highest
Price Target
0.735 EUR
326% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALVMG?

Click here to dive deeper.

Dividends

Visiomed Group SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALVMG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALVMG Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Visiomed Group SA Logo
Visiomed Group SA

Country

France

Industry

Health Care

Market Cap

50.8m EUR

Dividend Yield

0%

Description

Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.

Contact

ILE-DE-FRANCE
Puteaux
Tour PB5 1 Av du General de GAULLE
+33140670650
visiomed.fr

IPO

2011-07-05

Employees

67

Officers

CEO & Director
Mr. Clement Pacaud

See Also

Discover More
What is the Intrinsic Value of one ALVMG stock?

The intrinsic value of one ALVMG stock under the Base Case scenario is 0.3843 EUR.

Is ALVMG stock undervalued or overvalued?

Compared to the current market price of 0.1726 EUR, Visiomed Group SA is Undervalued by 55%.

Back to Top